Assessment of Pacing Stimulus Conduction and Latency Measurements in CRT-D Patients
NCT ID: NCT03314675
Last Updated: 2018-11-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
16 participants
INTERVENTIONAL
2018-02-26
2018-07-06
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Re-evaluation of Optimal Re-synchronisation Therapy in Patients With Chronic Heart Failure
NCT03494933
Observation of Clinical Routine Care for Heart Failure Patients Implanted With BIOTRONIK CRT Devices
NCT03366545
Cardiac Strains for Optimization of CRT in Non-Responders
NCT03803826
Evaluation of Left Ventricular Autothreshold, Phase Two
NCT01242722
Acute Optimization of Cardiac Resynchronization Therapy (CRT)Using Echocardiography and SonR
NCT01293526
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
CRT-D Measurements
Pre-specified measurements and additional follow-ups
BIOTRONIK CRT-D
Pre-specified follow-up and measurements
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
BIOTRONIK CRT-D
Pre-specified follow-up and measurements
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient successfully implanted with a left ventricular lead
* High likelihood of LV latency ≥ 40 ms
* LV lead in lateral or postero-lateral position in the coronary venous system
* Patient is able to understand the nature of the clinical investigation
* Patient is willing to undergo the required measurements at the investigation site
* Patient provides written informed consent
* Age ≥ 18 years
Exclusion Criteria
* Pregnant or breast-feeding women
* Participation in an interventional clinical investigation
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Biotronik SE & Co. KG
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Peter Nordbeck, PD Dr.
Role: PRINCIPAL_INVESTIGATOR
Wuerzburg University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ceske Budejovice hospital
České Budějovice, , Czechia
Institute for Clinical and Experimental Medicine
Prague, , Czechia
Herz- und Diabetiszentrum NRW
Bad Oeynhausen, , Germany
SRH Waldklinikum Gera GmbH
Gera, , Germany
Universitätsklinikum Gießen und Marburg
Giessen, , Germany
Universitätsklinikum Würzburg
Würzburg, , Germany
The Erasmus University Medical Center
Rotterdam, , Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CR022
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.